-
Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV TrialF Cosentino , CP Cannon , DZI Cherney et al. -
Heart Failure and Atrial Fibrillation, Like Fire and FuryMA Carlisle, M Fudim, AD DeVore et al.
-
Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic AnalysisAL Beale, S Nanayakkara, L Segan et al.
-
Modifiable lifestyle factors and heart failure: A Mendelian randomization studyS van Oort, JWJ Beulens, AJ van Ballegooijen et al.
-
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection FractionJ Tromp, L Shen, PS Jhund et al.
-
Association Between Functional Impairment and Medication Burden in Adults with Heart FailureGoyal P, Bryan J, Kneifati-Hayek J et al.
-
Clinical applications of machine learning in the diagnosis, classification, and prediction of heart failureCR Olsen, RJ Mentz, KJ Anstrom et al.
-
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of AmericaDunlay SM, Givertz MM, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
